Why Your Semaglutide Plateau Happens, and What to Do in 2026

A weight-loss plateau on semaglutide or tirzepatide is normal, and it usually shows up somewhere between 6 and 12 months in. In the STEP 5 trial, semaglutide's weight loss leveled off near week 60 and then held steady for the rest of two years. A stall is your body defending its weight, not the drug giving out. This guide covers when plateaus hit, why they happen, and the steps you and your physician can take next.

Is a semaglutide plateau normal?

Yes. Almost everyone on a GLP-1 hits a plateau. The steepest weight loss happens in the first few months, then the rate slows and the scale settles. For most people on compounded semaglutide or tirzepatide, that leveling-off lands somewhere around 6 to 12 months.

A plateau means your weight loss has stalled for several weeks in a row, not that you gained everything back. In trials, most people held their loss once they reached it. The key question is whether the stall is expected biology or a fixable gap in protein, sleep, or dose, and that is a conversation for you and your physician.

What a GLP-1 weight-loss plateau actually is

A GLP-1 plateau is a stretch of weeks where your weight holds flat even though you are still taking the medication and following your plan. It is the point where the calories you burn and the calories you eat come back into balance at a new, lower weight.

Semaglutide and tirzepatide work mainly by turning down appetite and quieting food noise. That effect does not switch off at a plateau. What changes is the math around it: as you get lighter, your body needs fewer calories, so the same appetite control no longer creates the same daily gap.

When plateaus tend to hit

Plateaus arrive on a fairly predictable schedule, and the timing differs a bit between the two medications. Trial data gives a useful map, though your own curve depends on your starting weight, your dose, and your habits.

People who start at a higher weight often keep losing a little longer before they settle. In SURMOUNT-1, those with class II or III obesity reached their plateau closer to week 36, while people in the overweight range settled nearer week 24.

Why your weight loss stalls

The main driver is metabolic adaptation. As you lose weight, your body burns fewer calories, both because there is less of you to move and because it actively dials down energy use to protect its stores.

• Your resting metabolism drops. Studies of weight loss show basal metabolic rate can fall by roughly 10 to 25 percent as people slim down.
• Your body burns fewer calories than its new size predicts. After about a 10 percent loss, some people burn 300 to 400 fewer calories a day than expected.
• Hunger and fullness hormones shift. Leptin, which signals fullness, drops, while ghrelin, which signals hunger, tends to rise.
• Muscle loss can deepen the stall. GLP-1s cut appetite, and if protein falls too low, the body can break down muscle, which lowers metabolism further.

Scientists describe this as the body defending a set point, its biologically preferred weight. It is the same reason weight loss without medication also plateaus. The GLP-1 lowers where that balance lands, but it does not erase the body's counter-response.

A plateau is not the drug failing

A stall feels like the medication stopped working. Usually it has not. In the trials, people who reached a plateau tended to hold that weight rather than regain it, which is a sign the medication is still doing its job.

Think of the first months as the loss phase and the plateau as the maintenance phase arriving. Holding a 15 to 20 percent lower weight is itself the medication working, since research shows weight tends to climb back after people stop a GLP-1 entirely. If you are weighing that decision, read coming off a GLP-1.

So the question at a plateau is rarely "does this still work?" It is "am I at a healthy landing spot, or is something fixable holding me short of it?" That is where a look at habits and dose comes in.

What you can do about a plateau

Most plateaus respond to a short checklist before anything about the medication changes. Work through these with your physician, since some overlap with dose decisions.

Give changes a few weeks. Daily weight bounces with water, salt, and hormones, so a true plateau is a flat trend over several weeks, not a heavy Monday. Keep expectations honest about pace, too, and see the GLP-1 weight-loss timeline for what each phase tends to look like.

Dose changes belong with your physician

One real reason for an early plateau is simply not being at your effective dose yet. Semaglutide and tirzepatide are titrated up in steps over months, and some people level off because they have more room to climb, not less.

This is a clinical decision, not a do-it-yourself one. A prescriber weighs your response, your side effects, and your goals before adjusting. Raising a dose too fast can worsen nausea without adding benefit. Some people also explore steadier, lower-step approaches; you can read about GLP-1 microdosing as one option to discuss.

When to talk with your clinician

A plateau on its own is expected. A few situations are worth a message to your prescriber sooner rather than later.

• You are steadily regaining weight, not just holding flat.
• You feel your appetite has fully returned to where it started.
• Side effects are limiting how much you can eat or drink.
• You have hit a weight you are happy with and want a maintenance plan.
• You are considering pausing or stopping the medication.

Choosing between the two medications is also a physician conversation. If you are curious how they differ, semaglutide vs tirzepatide lays out the trade-offs, and your prescriber confirms which fits you.

How pru handles GLP-1 plateaus

pru is a telehealth membership for compounded peptides. You select the medication you are interested in, and a licensed physician confirms whether it fits you. The doctor does not pick your product for you, and pru can't promise any specific amount of weight loss.

• Physician-led. A licensed prescriber reviews your intake, confirms fit, and manages any dose changes if you plateau.
• 503A pharmacy fill. Your medication is compounded and filled by an FDA-regulated 503A pharmacy. Compounded semaglutide and tirzepatide use the same active ingredient as the branded drugs; they are pharmacy-grade, not FDA-approved, and are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound.
• At-cost pricing. Membership runs about $50 a month, and peptides are billed at cost, itemized, with no member markup. A higher dose costs a little more because it is more medicine, never because of a markup.

pru's live weight-loss products are compounded semaglutide and tirzepatide. You can see both in the fat loss and metabolism category, and membership details are on the pricing page. Working through a plateau instead of quitting is the proactive move, and pru exists to make that smart choice the accessible one: licensed physicians, pharmacy-grade medicine, and at-cost pricing in one place. Take the next step when you are ready.

Related reading

• The GLP-1 weight-loss timeline: what to expect month by month
• How to keep muscle while losing weight on a GLP-1
• Quieting food noise on semaglutide and tirzepatide
• GLP-1 microdosing: what it means and who it is for
• Coming off a GLP-1 without undoing your progress
• Semaglutide vs tirzepatide: how they compare

Ready to start or continue? See pru's compounded weight-loss options.

Common questions